Causes of death in Korean patients with systemic lupus erythematosus: A single center retrospective study

Clinical and Experimental Rheumatology

Volumn 17, Issue 5, 1999, Pages 539-545

  Kim, W U ^a   Min, J K ^a   Lee, S H ^a   Park, S H ^a   Cho, C S ^a   Kim, H Y ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Cause of death; Korean; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; DISEASE ASSOCIATION; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; KOREA; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEPSIS; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIC PURPURA;

ADULT; BACTEREMIA; CAUSE OF DEATH; COHORT STUDIES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; KOREA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES;

EID: 0032858208     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. MERRILL M, SCHULMAN LE: Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chron Dis 1955; 1: 12-32.
2. UROWITZ MB, BOOKMAN AA, KOEHLER BE, GORDON DA, SMYTHE HA, OGRYZLO MA: The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60: 221-5.
3. GINZLER EM, DIAMOND HS, WEINER M, et al.: A multicenter study of outcome in systemic lupus erythematosus. 1. Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25: 601-11.
4. JONSSON H, NIVED O, STURFELT G: Outcome in systemic lupus erythematosus: A prospective study of patients of patients from a defined population. Medicine 1989; 68: 141-50.
5. REVEILLE JD, BARTOLUCCI A, ALARCON GS: Prognosis in systemic lupus erythematosus: Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990; 33: 37-48.
6. WARD MM, PYUN E, STUDENSKI S: Mortality risk associated with specific clinical manifestations of systemic lupus erythematosus. Arch Int Med 1996; 156: 1337-44.
7. WALLACE DJ, PODELL T, WEINER J, KLINENBERG JR, FOROUZESH S, DUBOIS EL: Systemic lupus erythematosus-survival pattern: Experience with 609 patients. JAMA 1981; 245: 934-8.
8. GUDMUNDSSON S, STEINSSON K: Systemic lupus erythematosus in Iceland 1975-1984: A nationwide epidemiological study in an unselected population. J Rheumatol 1990; 17: 1162-7.
9. HELLMANN DB, PETRI M, WHITING-O'KEEFE Q: Fetal infections in systemic lupus erythematosus: The role of opportunistic organism. Medicine (Baltimore) 1987; 66: 341-8.
10. WARD MM, PYUN E, STUDENSKI S: Causes of death in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 1492-9.
11. ROSNERS S, GINZLER EM, DIAMOND HS: A multicenter study of outcome in systemic lupus erythematosus: II. Causes of death. Arthritis Rheum 1982; 25: 612-7.
12. PETTERSSON T, PUKKALA E, TEPPO L, FRIMAN C: Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;51:437-9.
13. RAMSEY-GOLDMAN R, MATTAI SA, SCHILLING E, et al.: Increased risk of malignancy in patients with systemic lupus erythematosus. J Invest Med 1998; 46: 217-22.
14. OTTEN MW, TEUTSCH SM, WILLIAMSON DF, MARKS JS: The effect of known risk factors on the excess mortality of black adults in the United States. JAMA 1990; 263: 845-50.
15. MANTON KG, PATRICK CH, JOHNSON KW: Health differentials between blacks and whites: Recent trends in mortality and morbidity. Milbank Q 1987; 65 (Suppl. 1): 129-9.
16. SERDULA MK, RHOADS GG: Frequency of systemic lupus erythematosus (SLE) in different ethnic groups of Hawaii. Arthritis Rheum 1979; 22: 328-33.
17. SAMANTA A, FEEHALLY J, ROY S, NICHOL FE, SHELDON PJ, WALLS J: High prevalence of systemic disease and Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490-2.
18. LIANG M, PARTRIDGE AJ, DALTROY LJ, STRATTON KV̇, GALPER SR, HOLMAN HR: Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus. Arthritis Rheum 1991; 34: 1187-96.
19. TAN EM, COHEN AS, FRIES JF: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
20. COHEN AS, CANOSO JJ: Criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1972; 15: 540-3.
21. ABU-SHAKRA M, UROWITZ MB, GLADMAN DD, GOUGH J: Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 1995; 22: 1265-70.
22. STUDENSKI S, ALLEN NB, CALDWELL DS, RICE JR, POLISSON RP: Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 1987; 30: 1326-32.
23. HELVE T: Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol 1985; 14: 43-6.
24. SWAAK AJ, NOSSENT JC, BRONSVELD W et al.: Systemic lupus erythematosus: 1. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989; 48: 447-54.
25. ABU-SHAKRA M, UROWITZ MB, GLADMAN DD, GOUGH J: Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 1995; 22: 1259-64.
26. KOH ET, SEOW A, LEONG KH, CHNG HH: SLE mortality in an oriental population. Lupus 1997; 6: 27-31.
27. STAPLES PJ, GERDING DN, DECKER JL, GORDON RS JR: Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974; 17: 1-10.
28. NIVED O, STURFELT G, WOLLHEIM F: Systemic lupus erythematosus and infection: A controlled and prospective study including an epidemiological group. Q J Med 1985; 55: 271-87.
29. ABRAMSON S, KRAMER SB, RADIN A, HOLZMAN R: Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital. Arthritis Rheum 1985; 28: 75-9.
30. LEE P et al.: Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, asceptic necrosis and prognosis. Q J Med 1977; 66: 1-32.
31. PETRI M, GENOVESE M: Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins Lupus Cohort. J Rheumatol 1992; 19: 1559-65.
32. DUFFY KN, DUFFY CM, GLADMAN DD: Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients. J Rheumatol 1991; 18: 1180-4.
33. KATTWINKEL N, COOK L, AGNELLO V: Overwhelming fatal infection in a young woman after intravenous cyclophosphamide therapy for lupus nephritis. J Rheumatol 1991; 18: 79-81.
34. SIMONSON JS, SCHILLER NB, PETRI M, HELLMANN DB: Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989; 16: 918-25.
35. BADUI E, GARCIA-RUBI D, ROBLES E et al.: Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiol 1985; 36: 431-40.
36. PETRI M, SPENCE D, BONE LR, HOCHBERG MC: Coronary artery disease risk factors in the Johns Hopkins lupus cohorts: Prevalence, recognition by patients, and preventive practices. Medicine 1992; 71: 291-302.
37. TCHAI BS: Changes of plasma lipids and biochemical markers for coronary artery disease in Korea. Ann NY Acad Sci 1993; 676: 279-88.
38. KESTELOOT H, LEE CS, PARK HM et al.: A comparative study of serum lipids between Belgium and Korea. Circulation 1982; 65: 795-9.
39. SWEENEY DM, MANZI S, JANOSKY J, et al.: Risk of malignancy in women with systemic lupus erythematosus. J Rheumatol 1995; 22: 1478-82.